Eckert & Ziegler serves as a Contract Manufacturing Organization (CMO) for clinical as well as commercial supply for projects using alpha, beta, or gamma radiation.
Whether you require dedicated radionuclides in highest quality, radiolabeled pharmaceuticals or the manufacturing of medical devices, our team provides the ideal solutions customized to your pre-defined specifications.
A large number of radiopharmaceutical substances are in advanced clinical trials.
With our experience and capabilities in clinical scale manufacturing for phases I, II and III, the existing GMP production facilities as well as our comprehensive know-how in radiopharmaceuticals, we are your preferred contract manufacturing partner for all clinical phases.
Eckert & Ziegler also serves as a CMO for commercially oriented customers with radiopharmaceuticals and medical devices beyond clinical phases.
Our portfolio of spaces and buildings, as well as possibilities for extension, enables us to establish fully customized GLP and cGMP-compliant production facilities within a short time frame and our internal expertise will be used to cover all necessary services.
We are committed to providing holistic solutions as a contract manufacturer. That is why we round off our portfolio of services regarding the development and manufacturing of radiopharmaceuticals with additional support in logistical and regulatory matters. This includes packaging for radioactive substances, stability programs and product release plans, making us the one-stop-shop for all your radiopharmaceutical needs.
We are manufacturing partner for clinical supply of Bayer’s innovative Targeted Thorium Conjugates (TTCs) in Europe. TTCs are a next-generation targeted alpha therapy using the alpha-emitter Thorium-227. We are providing infrastructure for handling, manufacture and distribution of the TTCs for the purpose of clinical trial in Europe.
Sirtex is the manufacturer of SIR-Spheres® Y-90 resin microspheres, a medical device used in Selective Internal Radiation Therapy (SIRT) of liver cancer. We are in a long-term supply agreement for the use of our Yttrium-90 in SIR-Spheres®, supplying Sirtex’s sites in Frankfurt, Boston, and Singapore as a reliable partner.